Navigation Links
Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
Date:9/13/2007

Two-Day Multiplexing Technology Symposium Brings Together Thought Leaders in Life Sciences and Clinical Diagnostics to Share Ideas and Best Practices

OOSTERHOUT, Netherlands, Sept. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the world leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2007, the company's annual European end-user technology symposium. The two-day event will be held 2-3 October at the Berlage's Exchange in Amsterdam, the Netherlands, and will feature a range of presentations regarding Luminex's flexible xMAP(R) multiplexing technology in clinical diagnostics and life science research applications.

"We are thrilled to welcome xMAP technology end-users back to The Netherlands for our fifth annual Planet xMAP Europe," said Paul C. Ladestein, Director of European Operations for Luminex. "This event will allow scientists, researchers and clinicians to come together to share best practices and ideas not only about xMAP technology, but about the broader role that multiplexing technology is playing to improve research and enhance the quality of patient care."

Planet xMAP Europe 2007 will feature two days of presentations and workshops. Day One, Tuesday, 2 October, will concentrate on xMAP-based clinical diagnostics applications and include the following presentations:

-- Dr. John C. Carrano, Vice President, Research and Development Luminex Corporation (USA) - "xMAPing the Future: A Vision of Innovative Products and Dominant Solutions"

-- Dr. Susan J. Wong, Diagnostic Immunology Laboratory, Wadsworth Center NYSDOH (USA) - "Comparison of AtheNA Multi-Lyte Bb Microsphere Immunoassay to Two-Tier Serology for Laboratory Confirmation of Lyme Disease"

-- Dr. Mario J. Marcon, Director of Clinical/Molecular Microbiology, Virology, & Immunoserology, Department of Laboratory Medicine Children's Hospital, Columbus, OH (USA) - "Evaluation of the Plexus Epstein Barr Virus Panels in a children's Hospital Setting"

-- Professor Kai Zacharowski, M.D., Ph.D., Chair of Cardiovascular Anesthesia & Critical Care, Bristol Royal Infirmary (United Kingdom) - "Cytokines - From Head to Toe"

-- Dr. Diana Pauly, Center for Biological Safety, Microbial Toxins, Robert Koch-Institute (Germany) - "Simultaneous Detection of Bacterial and Plant Toxins Using a Multiplex Magnetic Bead Assay"

-- Dr. Gary T. Brice, United States Navy Medical Research Unit, Department of Immunology (Indonesia) - "Etiology of Respiratory Viral Pathogens in Suspect H5N1 Samples in Indonesia"

Day Two of Planet xMAP Europe 2007, Wednesday, 3 October, will focus on xMAP-based life science research applications and feature the following presentations:

-- Dr. Marion Lanteri, Postdoctoral Fellow, Immunology - "Cytokine Signature of Early Viral Infections"

-- Professor Thomas Herget, Ph.D., Director PLS R&D/New Technology Evaluation, Merck KGaA (Germany) - "Safety Biomarkers: Holy Grail of Toxicology"

-- Dr. Jochen Schwenk, KTH - Royal Institute of Technology, Alba Nova University Center, Department of Proteomics (Sweden) - "Multiplexed Approaches within Antibody Proteomics"

-- Dr. Corrado M. Cilio, Cellular Autoimmunity Unit, Department of Clinical Sciences and Pediatrics, Malmo University Hospital (Sweden) - "MicroRNA"

-- Dr. Oliver Poetz, NMI, Natural and Medical Science Institute at the University of Tuebingen (Germany) - "Magnetic Beads Work Better at Night"

-- Dr. Ben van Ommen, TNO Quality Life (The Netherlands), Head of Nutrigenomics and Nutritional Systems Biology Activities - "The Targeted Plasma Proteome in Personalized Health and Nutrition"

For additional information on Planet xMAP Europe 2007 or to register, please visit http://www.planetxmap.com or contact Jenny Busch (+31-162-408333 (332) or xmapeurope@luminexcorp.com).

About Luminex

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP(R) multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at http://www.luminexcorp.com.

Luminex Corporate Contact:

Harriss T. Currie

Vice President, Finance and Chief Financial Officer

512-219-8020

Luminex Media Contact:

Nicole Cottrill

327-327-7999


'/>"/>
SOURCE Luminex Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Bacterial RNA Isolation From Infected Eukaryotic Hosts
11. Bacterial RNA Isolation From Infected Eukaryotic Hosts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Feb. 12, 2016 Biocom, the association representing the ... a group of San Diego companies ... its 2016 Precision Medicine Advocacy Fly-In. Biocom Fly-In participants had ... Drug Administration (FDA), the Centers for Medicare and Medicaid Services ... San Diego U.S. Representatives Susan Davis and ...
(Date:2/12/2016)... 12, 2016  PTC Therapeutics, Inc. (NASDAQ: ... (Strategies to Realize Innovation, Vision and Empowerment) grant ... provides funds to patient advocacy organizations to develop ... contributions to the rare disease community by increasing ... patient advocates. Mary Frances Harmon ...
(Date:2/11/2016)... -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced its financial ... --> --> For the fourth ... million, or $0.34 loss per share, compared to a net loss ... period in 2014. For the year ended December 31, 2015, the ... per share, as compared to a net loss of $60.5 million, ...
(Date:2/11/2016)... -- Bioethics International, a not-for-profit organization focused on the ethics and ... accessible to patients around the world, today announced that the ... of the Good Pharma Scorecard an ,Editors, ... one of BMJ Open ,s ,Most Popular Articles, which ... frequently read. Ed Sucksmith , assistant editor of ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/18/2016)... JOSE, Calif. , Jan. 18, 2016 /PRNewswire/ ... security software that simplifies the use and access ... technology and go-to-market partnership with American Cyber.  ... Cyber brings extensive experience leading transformational C4ISR and ... implementing and integrating the latest proven technology solutions," ...
(Date:1/13/2016)... --> --> ... report titled - Biometric Sensors Market - Global Industry Analysis, ... to the report, the global biometric sensors market was valued at ... US$1,625.8 mn by 2023, expanding at a CAGR of ... the biometric sensors market is expected to reach 1,799.6 ...
Breaking Biology News(10 mins):